enVVeno Medical (NVNO) Net Margin (2017 - 2019)

enVVeno Medical's Net Margin history runs 3 years deep, the most recent figure standing at 5037.05% for Q1 2019.

• On a quarterly basis, Net Margin rose 1066109.0% year-over-year to 5037.05% in Q1 2019; TTM through Dec 2019 was 24406.74%, a 1564097.0% decrease from a year earlier, with the FY2019 full-year figure at 24406.74%, down 1564097.0% from the prior year.
• Net Margin climbed to 5037.05% in Q1 2019 per NVNO's latest filing, from 5848.74% in the prior quarter.
• Across five years, Net Margin topped out at 1857.18% in Q4 2017 and bottomed at 15698.14% in Q1 2018.
• The 3-year median for Net Margin is 5442.9% (2019), against an average of 6731.44%.
• Across the five-year window, Net Margin slumped 635592 bps in 2018 and soared 1066109 bps in 2019, its largest moves.
• Year by year, Net Margin stood at 1857.18% in 2017, then sank by 215 bps to 5848.74% in 2018, then gained by 14 bps to 5037.05% in 2019.
• Per Business Quant, the three latest NVNO Net Margin figures stand at 5037.05% (Q1 2019), 5848.74% (Q4 2018), and 3523.99% (Q3 2018).